The veterinary antimicrobial susceptibility testing market size has grown strongly in recent years. It will grow from $39.63 billion in 2025 to $42.73 billion in 2026 at a compound annual growth rate (CAGR) of 7.8%. The growth in the historic period can be attributed to establishment of veterinary diagnostic labs, rising prevalence of bacterial infections in livestock, limited awareness of antimicrobial resistance, traditional culture-based testing methods, government regulations supporting animal health.
The veterinary antimicrobial susceptibility testing market size is expected to see strong growth in the next few years. It will grow to $57.94 billion in 2030 at a compound annual growth rate (CAGR) of 7.9%. The growth in the forecast period can be attributed to advancement in automated ast technologies, increasing adoption of precision medicine in veterinary care, growing companion animal population, rising investments in veterinary research, integration of cloud-based diagnostic data management. Major trends in the forecast period include rapid adoption of automated ast instruments, increasing demand for companion animal healthcare, growing awareness of antimicrobial resistance, expansion of veterinary reference laboratories, integration of advanced diagnostic workflows.
The rise in pet ownership is expected to drive growth in the veterinary antimicrobial susceptibility testing market in the coming years. Pet ownership refers to having and caring for a domesticated animal as a companion or family member. The increase in pet ownership is fueled by the desire for emotional companionship, with more households adopting pets for stress relief and improved mental well-being. Veterinary antimicrobial susceptibility testing supports pet health by ensuring effective treatment of infections, reducing illness duration, and maintaining overall well-being. For example, in 2023, according to Shelter Animals Count, a US-based non-governmental organization, 4.8 million animals in shelters and rescues were adopted into loving homes. Therefore, increasing pet ownership is driving the veterinary antimicrobial susceptibility testing market.
Leading players in the veterinary antimicrobial susceptibility testing market are introducing innovative products, such as rapid tests, to maintain their market position. Rapid tests, also called rapid diagnostic tests (RDTs) or rapid assays, are designed to provide results within a short time. For instance, in March 2023, PDX Biotech LLC, a US-based biotechnology company, launched the OraStripdx, a rapid test that detects active periodontal disease in dogs and cats within 10 seconds. The OraStripdx uses an easy-to-use test strip that changes color based on thiol concentrations in oral fluid, requiring no anesthesia or sedation. It can detect disease development in areas that are not directly visible, enabling pet owners and veterinary professionals to identify conditions at the earliest stages - a significant advantage.
In September 2023, Mars Incorporated, a US-based diversified manufacturing and pet health company, acquired SYNLAB Vet for an undisclosed amount. Through this acquisition, Mars aimed to expand its veterinary diagnostics and technology capabilities across Europe and strengthen its pet healthcare solutions within the Mars Petcare Science & Diagnostics division. SYNLAB Vet is a Germany-based veterinary diagnostics company specializing in providing laboratory diagnostic services and related technology solutions to veterinary professionals.
Major companies operating in the veterinary antimicrobial susceptibility testing market are BioMérieux SA, Becton, Dickinson and Company, Bio-Rad Laboratories, Bruker Corporation, Condalab SA, FASTinov SA, Hardy Diagnostics Co., HiMedia Laboratories, Liofilchem Srl, Mast Group Ltd., Neogen Corporation, SSI Diagnostica A/S, Synbiosis, Thermo Fisher Scientific Inc., Accelerate Diagnostics Inc., Alifax S.r.l., Biogal Galed Labs Ltd., Creative Diagnostics, Danaher Corporation, Eurofins Scientific SE, IDEXX Laboratories Inc., Merck Co. & KGaA, Microbiologics Inc., QIAGEN N.V., R-Biopharm AG, T2 Biosystems Inc., Vetoquinol S.A., Virbac Inc., Zoetis Inc.
North America was the largest region in the veterinary antimicrobial susceptibility testing market in 2025. The regions covered in the veterinary antimicrobial susceptibility testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the veterinary antimicrobial susceptibility testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs have influenced the veterinary antimicrobial susceptibility testing market by increasing the cost of imported laboratory equipment, culture media, and consumables. This has primarily affected automated AST instruments and accessories in regions such as north america and europe, where imports form a significant portion of supply. Some positive impacts include encouraging local manufacturing and fostering innovation in cost-effective alternatives, which may strengthen domestic production and reduce dependency on global supply chains.
The veterinary antimicrobial susceptibility testing market research report is one of a series of new reports that provides veterinary antimicrobial susceptibility testing market statistics, including veterinary antimicrobial susceptibility testing industry global market size, regional shares, competitors with a veterinary antimicrobial susceptibility testing market share, detailed veterinary antimicrobial susceptibility testing market segments, market trends and opportunities, and any further data you may need to thrive in the veterinary antimicrobial susceptibility testing industry. This veterinary antimicrobial susceptibility testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Veterinary antimicrobial susceptibility testing serves as a crucial tool for veterinarians to select the most effective drugs for treating bacterial infections in animals. It aids in providing a comprehensive treatment history, encompassing prior antibiotic usage and relevant clinical background that could impact the animal's typical bacterial flora.
The primary product categories within veterinary antimicrobial susceptibility testing comprise disks and plates, culture media, accessories and consumables, and automated AST (antimicrobial susceptibility test) instruments. Disks and plates, small circular filter paper pieces soaked in antibiotic solutions and dried, are utilized to determine the antibiotics to which an infectious organism is susceptible. This information allows healthcare professionals to administer the appropriate medication. This testing is conducted on both livestock and companion animals, carried out in veterinary reference laboratories, veterinary research institutes, and other related facilities.
The veterinary antimicrobial susceptibility testing market consists of revenues earned by entities by providing the disk diffusion technique and the broth dilution technique. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The veterinary antimicrobial susceptibility testing market size is expected to see strong growth in the next few years. It will grow to $57.94 billion in 2030 at a compound annual growth rate (CAGR) of 7.9%. The growth in the forecast period can be attributed to advancement in automated ast technologies, increasing adoption of precision medicine in veterinary care, growing companion animal population, rising investments in veterinary research, integration of cloud-based diagnostic data management. Major trends in the forecast period include rapid adoption of automated ast instruments, increasing demand for companion animal healthcare, growing awareness of antimicrobial resistance, expansion of veterinary reference laboratories, integration of advanced diagnostic workflows.
The rise in pet ownership is expected to drive growth in the veterinary antimicrobial susceptibility testing market in the coming years. Pet ownership refers to having and caring for a domesticated animal as a companion or family member. The increase in pet ownership is fueled by the desire for emotional companionship, with more households adopting pets for stress relief and improved mental well-being. Veterinary antimicrobial susceptibility testing supports pet health by ensuring effective treatment of infections, reducing illness duration, and maintaining overall well-being. For example, in 2023, according to Shelter Animals Count, a US-based non-governmental organization, 4.8 million animals in shelters and rescues were adopted into loving homes. Therefore, increasing pet ownership is driving the veterinary antimicrobial susceptibility testing market.
Leading players in the veterinary antimicrobial susceptibility testing market are introducing innovative products, such as rapid tests, to maintain their market position. Rapid tests, also called rapid diagnostic tests (RDTs) or rapid assays, are designed to provide results within a short time. For instance, in March 2023, PDX Biotech LLC, a US-based biotechnology company, launched the OraStripdx, a rapid test that detects active periodontal disease in dogs and cats within 10 seconds. The OraStripdx uses an easy-to-use test strip that changes color based on thiol concentrations in oral fluid, requiring no anesthesia or sedation. It can detect disease development in areas that are not directly visible, enabling pet owners and veterinary professionals to identify conditions at the earliest stages - a significant advantage.
In September 2023, Mars Incorporated, a US-based diversified manufacturing and pet health company, acquired SYNLAB Vet for an undisclosed amount. Through this acquisition, Mars aimed to expand its veterinary diagnostics and technology capabilities across Europe and strengthen its pet healthcare solutions within the Mars Petcare Science & Diagnostics division. SYNLAB Vet is a Germany-based veterinary diagnostics company specializing in providing laboratory diagnostic services and related technology solutions to veterinary professionals.
Major companies operating in the veterinary antimicrobial susceptibility testing market are BioMérieux SA, Becton, Dickinson and Company, Bio-Rad Laboratories, Bruker Corporation, Condalab SA, FASTinov SA, Hardy Diagnostics Co., HiMedia Laboratories, Liofilchem Srl, Mast Group Ltd., Neogen Corporation, SSI Diagnostica A/S, Synbiosis, Thermo Fisher Scientific Inc., Accelerate Diagnostics Inc., Alifax S.r.l., Biogal Galed Labs Ltd., Creative Diagnostics, Danaher Corporation, Eurofins Scientific SE, IDEXX Laboratories Inc., Merck Co. & KGaA, Microbiologics Inc., QIAGEN N.V., R-Biopharm AG, T2 Biosystems Inc., Vetoquinol S.A., Virbac Inc., Zoetis Inc.
North America was the largest region in the veterinary antimicrobial susceptibility testing market in 2025. The regions covered in the veterinary antimicrobial susceptibility testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the veterinary antimicrobial susceptibility testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs have influenced the veterinary antimicrobial susceptibility testing market by increasing the cost of imported laboratory equipment, culture media, and consumables. This has primarily affected automated AST instruments and accessories in regions such as north america and europe, where imports form a significant portion of supply. Some positive impacts include encouraging local manufacturing and fostering innovation in cost-effective alternatives, which may strengthen domestic production and reduce dependency on global supply chains.
The veterinary antimicrobial susceptibility testing market research report is one of a series of new reports that provides veterinary antimicrobial susceptibility testing market statistics, including veterinary antimicrobial susceptibility testing industry global market size, regional shares, competitors with a veterinary antimicrobial susceptibility testing market share, detailed veterinary antimicrobial susceptibility testing market segments, market trends and opportunities, and any further data you may need to thrive in the veterinary antimicrobial susceptibility testing industry. This veterinary antimicrobial susceptibility testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Veterinary antimicrobial susceptibility testing serves as a crucial tool for veterinarians to select the most effective drugs for treating bacterial infections in animals. It aids in providing a comprehensive treatment history, encompassing prior antibiotic usage and relevant clinical background that could impact the animal's typical bacterial flora.
The primary product categories within veterinary antimicrobial susceptibility testing comprise disks and plates, culture media, accessories and consumables, and automated AST (antimicrobial susceptibility test) instruments. Disks and plates, small circular filter paper pieces soaked in antibiotic solutions and dried, are utilized to determine the antibiotics to which an infectious organism is susceptible. This information allows healthcare professionals to administer the appropriate medication. This testing is conducted on both livestock and companion animals, carried out in veterinary reference laboratories, veterinary research institutes, and other related facilities.
The veterinary antimicrobial susceptibility testing market consists of revenues earned by entities by providing the disk diffusion technique and the broth dilution technique. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Veterinary Antimicrobial Susceptibility Testing Market Characteristics
3. Veterinary Antimicrobial Susceptibility Testing Market Supply Chain Analysis
4. Global Veterinary Antimicrobial Susceptibility Testing Market Trends and Strategies
5. Veterinary Antimicrobial Susceptibility Testing Market Analysis of End Use Industries
7. Global Veterinary Antimicrobial Susceptibility Testing Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Veterinary Antimicrobial Susceptibility Testing Total Addressable Market (TAM) Analysis for the Market
9. Veterinary Antimicrobial Susceptibility Testing Market Segmentation
10. Veterinary Antimicrobial Susceptibility Testing Market Regional and Country Analysis
11. Asia-Pacific Veterinary Antimicrobial Susceptibility Testing Market
12. China Veterinary Antimicrobial Susceptibility Testing Market
13. India Veterinary Antimicrobial Susceptibility Testing Market
14. Japan Veterinary Antimicrobial Susceptibility Testing Market
15. Australia Veterinary Antimicrobial Susceptibility Testing Market
16. Indonesia Veterinary Antimicrobial Susceptibility Testing Market
17. South Korea Veterinary Antimicrobial Susceptibility Testing Market
18. Taiwan Veterinary Antimicrobial Susceptibility Testing Market
19. South East Asia Veterinary Antimicrobial Susceptibility Testing Market
20. Western Europe Veterinary Antimicrobial Susceptibility Testing Market
21. UK Veterinary Antimicrobial Susceptibility Testing Market
22. Germany Veterinary Antimicrobial Susceptibility Testing Market
23. France Veterinary Antimicrobial Susceptibility Testing Market
24. Italy Veterinary Antimicrobial Susceptibility Testing Market
25. Spain Veterinary Antimicrobial Susceptibility Testing Market
26. Eastern Europe Veterinary Antimicrobial Susceptibility Testing Market
27. Russia Veterinary Antimicrobial Susceptibility Testing Market
28. North America Veterinary Antimicrobial Susceptibility Testing Market
29. USA Veterinary Antimicrobial Susceptibility Testing Market
30. Canada Veterinary Antimicrobial Susceptibility Testing Market
31. South America Veterinary Antimicrobial Susceptibility Testing Market
32. Brazil Veterinary Antimicrobial Susceptibility Testing Market
33. Middle East Veterinary Antimicrobial Susceptibility Testing Market
34. Africa Veterinary Antimicrobial Susceptibility Testing Market
36. Veterinary Antimicrobial Susceptibility Testing Market Competitive Landscape and Company Profiles
37. Veterinary Antimicrobial Susceptibility Testing Market Other Major and Innovative Companies
40. Veterinary Antimicrobial Susceptibility Testing Market High Potential Countries, Segments and Strategies
41. Appendix
Executive Summary
Veterinary Antimicrobial Susceptibility Testing Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses veterinary antimicrobial susceptibility testing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for veterinary antimicrobial susceptibility testing? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The veterinary antimicrobial susceptibility testing market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Product Type: Disks And Plates; Culture Media; Accessories And Consumables; Automated Antimicrobial Susceptibility Test (AST) Instruments2) By Animal Type: Livestock Animals; Companion Animals
3) By End-Use: Veterinary Reference Lab; Veterinary Research Institutes; Other End-Users
Subsegments:
1) By Disks And Plates: Antibiotic Disks; Agar Plates2) By Culture Media: Selective Culture Media; General Purpose Media
3) By Accessories And Consumables: Incubators; Sterilization Equipment; Pipettes And Reagents
4) By Automated Antimicrobial Susceptibility Test (AST) Instruments: Fully Automated Systems; Semi-Automated Systems
Companies Mentioned: BioMérieux SA; Becton, Dickinson and Company; Bio-Rad Laboratories; Bruker Corporation; Condalab SA; FASTinov SA; Hardy Diagnostics Co.; HiMedia Laboratories; Liofilchem Srl; Mast Group Ltd.; Neogen Corporation; SSI Diagnostica A/S; Synbiosis; Thermo Fisher Scientific Inc.; Accelerate Diagnostics Inc.; Alifax S.r.l.; Biogal Galed Labs Ltd.; Creative Diagnostics; Danaher Corporation; Eurofins Scientific SE; IDEXX Laboratories Inc.; Merck Co. & KGaA; Microbiologics Inc.; QIAGEN N.V.; R-Biopharm AG; T2 Biosystems Inc.; Vetoquinol S.A.; Virbac Inc.; Zoetis Inc.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Veterinary Antimicrobial Susceptibility Testing market report include:- BioMérieux SA
- Becton, Dickinson and Company
- Bio-Rad Laboratories
- Bruker Corporation
- Condalab SA
- FASTinov SA
- Hardy Diagnostics Co.
- HiMedia Laboratories
- Liofilchem Srl
- Mast Group Ltd.
- Neogen Corporation
- SSI Diagnostica A/S
- Synbiosis
- Thermo Fisher Scientific Inc.
- Accelerate Diagnostics Inc.
- Alifax S.r.l.
- Biogal Galed Labs Ltd.
- Creative Diagnostics
- Danaher Corporation
- Eurofins Scientific SE
- IDEXX Laboratories Inc.
- Merck Co. & KGaA
- Microbiologics Inc.
- QIAGEN N.V.
- R-Biopharm AG
- T2 Biosystems Inc.
- Vetoquinol S.A.
- Virbac Inc.
- Zoetis Inc.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 42.73 Billion |
| Forecasted Market Value ( USD | $ 57.94 Billion |
| Compound Annual Growth Rate | 7.9% |
| Regions Covered | Global |
| No. of Companies Mentioned | 29 |
